Print

ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Fourth Quarter and Fiscal Year 2012 Financial Results  
7/26/2012 11:33:40 AM

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 3, 2012, to discuss ImmunoGen's financial results for the three-month period and fiscal year ended June 30, 2012. Management also will provide an update on the Company and guidance for ImmunoGen’s fiscal year ending June 30, 2013.
//-->